Tenet Healthcare (THC) Cash from Financing Activities (2009 - 2026)

Tenet Healthcare has reported Cash from Financing Activities for 18 years, with the latest figure at -$1.2 billion in Q2 2026.

• Quarterly Cash from Financing Activities fell 18.37% year-over-year to -$1.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$3.2 billion (down 26.33% YoY) and the FY2025 annual result came in at -$2.4 billion, up 34.84% from the prior year.
• Cash from Financing Activities rose to -$1.2 billion in Q2 2026 per THC's latest filing, from -$1.2 billion in the prior quarter.
• Over five years, Cash from Financing Activities peaked at -$33.0 million in Q2 2022 and troughed at -$2.7 billion in Q1 2024.
• A 5-year average of -$628.9 million and a median of -$403.0 million in 2024 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities soared 88.28% in 2022, then tumbled 943.53% in 2024.
• Over 5 years, Cash from Financing Activities stood at -$465.0 million in 2022, then jumped by 31.83% to -$317.0 million in 2023, then retreated by 17.35% to -$372.0 million in 2024, then fell by 16.67% to -$434.0 million in 2025, then tumbled by 171.66% to -$1.2 billion in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$1.2 billion, -$1.2 billion, and -$434.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.